These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 33285567)

  • 1. Design of an epitope-based peptide vaccine against the SARS-CoV-2: a vaccine-informatics approach.
    Alam A; Khan A; Imam N; Siddiqui MF; Waseem M; Malik MZ; Ishrat R
    Brief Bioinform; 2021 Mar; 22(2):1309-1323. PubMed ID: 33285567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3CL hydrolase-based multiepitope peptide vaccine against SARS-CoV-2 using immunoinformatics.
    Jakhar R; Kaushik S; Gakhar SK
    J Med Virol; 2020 Oct; 92(10):2114-2123. PubMed ID: 32379348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Landscape and selection of vaccine epitopes in SARS-CoV-2.
    Smith CC; Olsen KS; Gentry KM; Sambade M; Beck W; Garness J; Entwistle S; Willis C; Vensko S; Woods A; Fini M; Carpenter B; Routh E; Kodysh J; O'Donnell T; Haber C; Heiss K; Stadler V; Garrison E; Sandor AM; Ting JPY; Weiss J; Krajewski K; Grant OC; Woods RJ; Heise M; Vincent BG; Rubinsteyn A
    Genome Med; 2021 Jun; 13(1):101. PubMed ID: 34127050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immuno-informatics analysis predicts B and T cell consensus epitopes for designing peptide vaccine against SARS-CoV-2 with 99.82% global population coverage.
    Shukla P; Pandey P; Prasad B; Robinson T; Purohit R; D'Cruz LG; Tambuwala MM; Mutreja A; Harkin J; Rai TS; Murray EK; Gibson DS; Bjourson AJ
    Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34962259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immuno-informatics approach for B-cell and T-cell epitope based peptide vaccine design against novel COVID-19 virus.
    Singh J; Malik D; Raina A
    Vaccine; 2021 Feb; 39(7):1087-1095. PubMed ID: 33478787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiepitope Subunit Vaccine Design against COVID-19 Based on the Spike Protein of SARS-CoV-2: An
    Dar HA; Waheed Y; Najmi MH; Ismail S; Hetta HF; Ali A; Muhammad K
    J Immunol Res; 2020; 2020():8893483. PubMed ID: 33274246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revelation of Potent Epitopes Present in Unannotated ORF Antigens of SARS-CoV-2 for Epitope-Based Polyvalent Vaccine Design Using Immunoinformatics Approach.
    Uttamrao PP; Sathyaseelan C; Patro LPP; Rathinavelan T
    Front Immunol; 2021; 12():692937. PubMed ID: 34497604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epitope-based peptide vaccine design and target site depiction against Middle East Respiratory Syndrome Coronavirus: an immune-informatics study.
    Tahir Ul Qamar M; Saleem S; Ashfaq UA; Bari A; Anwar F; Alqahtani S
    J Transl Med; 2019 Nov; 17(1):362. PubMed ID: 31703698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An in silico deep learning approach to multi-epitope vaccine design: a SARS-CoV-2 case study.
    Yang Z; Bogdan P; Nazarian S
    Sci Rep; 2021 Feb; 11(1):3238. PubMed ID: 33547334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoinformatics and Molecular Docking Studies Predicted Potential Multiepitope-Based Peptide Vaccine and Novel Compounds against Novel SARS-CoV-2 through Virtual Screening.
    Waqas M; Haider A; Rehman A; Qasim M; Umar A; Sufyan M; Akram HN; Mir A; Razzaq R; Rasool D; Tahir RA; Sehgal SA
    Biomed Res Int; 2021; 2021():1596834. PubMed ID: 33728324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of multi-epitope peptide-based vaccines against SARS-CoV-2.
    Lim HX; Lim J; Jazayeri SD; Poppema S; Poh CL
    Biomed J; 2021 Mar; 44(1):18-30. PubMed ID: 33727051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A reverse vaccinology and immunoinformatics approach for designing a multiepitope vaccine against SARS-CoV-2.
    Jahangirian E; Jamal GA; Nouroozi M; Mohammadpour A
    Immunogenetics; 2021 Dec; 73(6):459-477. PubMed ID: 34542663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immuno-informatics design of a multimeric epitope peptide based vaccine targeting SARS-CoV-2 spike glycoprotein.
    Chukwudozie OS; Gray CM; Fagbayi TA; Chukwuanukwu RC; Oyebanji VO; Bankole TT; Adewole RA; Daniel EM
    PLoS One; 2021; 16(3):e0248061. PubMed ID: 33730022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoinformatics-guided design of an epitope-based vaccine against severe acute respiratory syndrome coronavirus 2 spike glycoprotein.
    Rakib A; Sami SA; Mimi NJ; Chowdhury MM; Eva TA; Nainu F; Paul A; Shahriar A; Tareq AM; Emon NU; Chakraborty S; Shil S; Mily SJ; Ben Hadda T; Almalki FA; Emran TB
    Comput Biol Med; 2020 Sep; 124():103967. PubMed ID: 32828069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine design based on 16 epitopes of SARS-CoV-2 spike protein.
    He J; Huang F; Zhang J; Chen Q; Zheng Z; Zhou Q; Chen D; Li J; Chen J
    J Med Virol; 2021 Apr; 93(4):2115-2131. PubMed ID: 33091154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epitope-based peptide vaccines predicted against novel coronavirus disease caused by SARS-CoV-2.
    Lin L; Ting S; Yufei H; Wendong L; Yubo F; Jing Z
    Virus Res; 2020 Oct; 288():198082. PubMed ID: 32621841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 coronavirus vaccine T cell epitope prediction analysis based on distributions of HLA class I loci (HLA-A, -B, -C) across global populations.
    Cun Y; Li C; Shi L; Sun M; Dai S; Sun L; Shi L; Yao Y
    Hum Vaccin Immunother; 2021 Apr; 17(4):1097-1108. PubMed ID: 33175614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoinformatics prediction of overlapping CD8
    Fatoba AJ; Maharaj L; Adeleke VT; Okpeku M; Adeniyi AA; Adeleke MA
    Vaccine; 2021 Feb; 39(7):1111-1121. PubMed ID: 33478794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of an epitope-based peptide vaccine against spike protein of human coronavirus: an in silico approach.
    Oany AR; Emran AA; Jyoti TP
    Drug Des Devel Ther; 2014; 8():1139-49. PubMed ID: 25187696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A vaccine built from potential immunogenic pieces derived from the SARS-CoV-2 spike glycoprotein: A computational approximation.
    Marchan J
    J Immunol Methods; 2022 Mar; 502():113216. PubMed ID: 35007561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.